Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ty, Elders"'
Publikováno v:
International Journal of Infectious Diseases, Vol 112, Iss , Pp 73-75 (2021)
SARS-CoV-2 monoclonal antibodies (mAbs) have been proposed as a treatment for mild to moderate COVID-19, with favorable outcomes reported in clinical trials and an emergency use authorization granted by the Food and Drug Administration. Real-world da
Externí odkaz:
https://doaj.org/article/05b2db2ae16a4bb2be783a8b09ce7830
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 112, Iss, Pp 73-75 (2021)
International Journal of Infectious Diseases, Vol 112, Iss, Pp 73-75 (2021)
SARS-CoV-2 monoclonal antibodies (mAbs) have been proposed as a treatment for mild to moderate COVID-19, with favorable outcomes reported in clinical trials and an emergency use authorization granted by the Food and Drug Administration. Real-world da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd41199043c312dce6eff3ec32952344
https://doi.org/10.1016/j.ijid.2021.09.007
https://doi.org/10.1016/j.ijid.2021.09.007
Publikováno v:
American Journal of Health-System Pharmacy. 77:632-635
Purpose Monitoring of procalcitonin (PCT) levels may support appropriate antibiotic discontinuation. The purpose of this study was to determine the current state of PCT monitoring at community hospitals across the United States. Methods Data from adu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc16094218e4f93fba7244a410b569ca
https://doi.org/10.1093/ajhp/zxaa028
https://doi.org/10.1093/ajhp/zxaa028
Publikováno v:
American Journal of Health-System Pharmacy. 75:S82-S86
Purpose The use of a clinical decision support (CDS) tool to determine patients’ eligibility for oral medication therapy and the opportunity cost of i.v.-to-oral conversion practices in a large health system was evaluated. Methods This multicenter,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a35c90d6d279d8e2879ca0a6ec56665d
https://doi.org/10.2146/ajhp170405
https://doi.org/10.2146/ajhp170405
Use of clinical decision support to identify i.v.-to-oral conversion opportunities and cost savings.
Autor:
H., Carver Kenneth1 (AUTHOR) kenneth.carver@hcahealthcare.com, Hayley, Burgess L.1 (AUTHOR), Mandelin, Cooper1 (AUTHOR), Ty, Elders1 (AUTHOR), Joan, Kramer1 (AUTHOR)
Publikováno v:
American Journal of Health-System Pharmacy. 2018 Supplement 4, Vol. 75, pS82-S86. 5p. 3 Charts.